Jacques Corman
University of Colorado Boulder
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jacques Corman.
The New England Journal of Medicine | 1973
Shunzaburo Iwatsuki; Mordecai M. Popovtzer; Jacques Corman; Makoto Ishikawa; Charles W. Putnam; Fred H. Katz; Thomas E. Starzl
Abstract Three patients with progressive renal failure and advanced hepatic insufficiency due to cirrhosis of the liver underwent orthotopic liver transplantation. All three patients had immediate improvement in hepatic function and within two weeks after liver replacement regained nearly normal kidney function. However, the renal recovery was delayed in each case, and its course was not uniform. Plasma renin activity was high, and renin substrate was low before transplantation in one case in which these measurements were obtained; both returned to normal soon after liver replacement. (N Engl J Med 289:1155–1159, 1973)
Circulation | 1973
Mordecai M. Popovtzer; Wulf Pinnggera; Fred H. Katz; Jacques Corman; John B. Robinette; Bernard Lanois; Charles G. Halgrimson; Thomas E. Starzl
The course of hypertension within the first 2 months after kidney transplantation was correlated with renal function, plasma renin activity (PRA), and the daily maintenance dose of prednisone in 18 homograft recipients. During acute rejection blood pressure (BP) closely correlated with PRA. Patients with normal homograft function showed an increase in BP early after transplantation which in most returned to normal 3-8 weeks later. In the latter group no correlation could be found between the level of BP and PRA, however the BP correlated closely with the dose of prednisone. These observations suggest that during acute rejection the increase in BP may at least partly be mediated by a renal pressor mechanism, whereas with normal renal function the high dose of glucocorticoids may play an important role in the development of hypertension.
Transplantation | 1973
Jacques Corman; Noboru Kashiwagi; K. A. Porter; G. Andres; Shunzaburo Iwatsuki; Charles W. Putnam; Mordecai M. Popovtzer; Israel Penn; Thomas E. Starzl
The presence of preformed cytotoxic antidonor antibodies in the serum of potential allograft recipients leads to the rapid destruction of the graft by the now well known events of hyperacute rejection (10, 21, 24-27). Experimental work in the past several years at our center and in other laboratories has been oriented to the solution of this difficult immunological problem, not only in the presensitized homotransplantation model but also in strongly incompatible xenograft combinations. Antibody and complement depletion (3-5, 7, 8, 13, 16, 19, 21, 23), or treatment by the chelating agents, sodium citrate (12, 14) and ethylenediaminetetraacetate (EDTA) (1), has been shown to delay hyperacute kidney rejection in both experimental models, whereas anticoagulation with heparin (15) or cobra venom (6) has yielded equivocal results. Even the most effective of these therapeutic procedures only delayed the destruction of the graft. More recently, encouraging results were obtained by several workers (11, 20, 22) with pretreatment of the organ with antidonor IgG fragments (F(ab′)2). It was suggested that F(ab′)2 fragments were protective by occupying the donor antigen receptor sites. Unsuccessful attempts to control hyperacute rejection in one of our patients who had preformed circulating cytotoxic antibodies are reported here, using homografts pretreated with sodium citrate or digested IgG.
The New England Journal of Medicine | 1973
Thomas E. Starzl; Kendrick A. Porter; Gerhard P. J. Schröter; Jacques Corman; Carl-Gustav Groth; Harvey L. Sharp
IT has been a little more than five years since the first extended survival was achieved after human liver transplantation, and for that reason individual cases are still of special interest. For a...
Transplantation proceedings | 1973
Carl G. Groth; Reuben S. Dubois; Jacques Corman; Ake Gustafsson; Shunzaburo Iwatsuki; Denis O. Rodgerson; Charles G. Halgrimson; Thomas E. Starzl
The Journal of Nuclear Medicine | 1973
William C. Klingensmith; Thomas W. Ryerson; Jacques Corman
Transplantation | 1973
Philip Belitsky; Mordecai M. Popovtzer; Jacques Corman; Bernard Launois; Kendrick A. Porter
Transplantation proceedings | 1972
Thomas E. Starzl; Jacques Corman; Carl G. Groth; Charles G. Halgrimson; Israel Penn; Charles W. Putnam; Gerhard P. J. Schröter; Ake Gustafsson
Transplantation proceedings | 1972
Thomas E. Starzl; Carl G. Groth; Noboru Kashiwagi; Charles W. Putnam; Jacques Corman; Charles G. Halgrimson; Israel Penn
Transplantation proceedings | 1973
Charles G. Halgrimson; Israel Penn; Arthur S. Booth; Carl G. Groth; C. W. Putnam; Jacques Corman; Thomas E. Starzl